NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Thursday reported fourth-quarter profit of $494 million.

On a per-share basis, the New York-based company said it had net income of 83 cents. Earnings, adjusted for non-recurring costs, came to $1.15 per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.03 per share.

The company posted revenue of $596 million in the period. Its adjusted revenue was $736 million.

For the year, the company reported profit of $1.14 billion, or $1.88 per share. Revenue was reported as $3.05 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPRX at https://www.zacks.com/ap/RPRX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News